Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingWages, Salaries and Other
Ratios

Marimed (MRMD) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $394.5 million.

  • Marimed's Shares Outstanding rose 353.29% to $394.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $394.5 million, marking a year-over-year increase of 353.29%. This contributed to the annual value of $381.5 million for FY2024, which is 169.28% up from last year.
  • Marimed's Shares Outstanding amounted to $394.5 million in Q3 2025, which was up 353.29% from $392.0 million recorded in Q2 2025.
  • In the past 5 years, Marimed's Shares Outstanding registered a high of $394.5 million during Q3 2025, and its lowest value of $322.5 million during Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding was $371.6 million (2023), whereas its average is $359.7 million.
  • In the last 5 years, Marimed's Shares Outstanding skyrocketed by 3704.68% in 2021 and then skyrocketed by 136.23% in 2024.
  • Over the past 5 years, Marimed's Shares Outstanding (Quarter) stood at $334.0 million in 2021, then grew by 2.23% to $341.5 million in 2022, then rose by 9.85% to $375.1 million in 2023, then rose by 1.69% to $381.5 million in 2024, then grew by 3.4% to $394.5 million in 2025.
  • Its Shares Outstanding stands at $394.5 million for Q3 2025, versus $392.0 million for Q2 2025 and $388.7 million for Q1 2025.